Gabriel Aleixo
@chefaleixomd
Followers
3K
Following
11K
Media
80
Statuses
2K
Penny’s dad. from chef to MD, from 🇧🇷 to 🇺🇸, IM at @clevelandclinic, Hemonc fellow at @pennmedicine. Views and opinions are my own.
Philadelphia, PA
Joined March 2017
I am incredibly happy and thankful for all the support from my mentors and from @CCF_IMCHIEFS . I will be a hemonc doc by University of Pennsylvania Most sincere Obrigado 😊 @DrHymanMuss @BldCancerDoc @jamecancerdoc @HalleMooreMD @DrStephValente @GrantWilliamsMD
43
9
251
This is gold !!!
0
0
5
Incredibly proud of our team @PrincetonHealth @PC3Innovation for our @ACCCBuzz 2025 Innovator Award for Implementing a Structured, Scalable Geriatric Oncology Program https://t.co/IxDhyRmRKm Our older patients matter & it is a privilege to serve this underrepresented group
1
2
13
“Quality or quantity of life” 🔗 https://t.co/tYDxyHMMVf In 181 patients ≥65 at a community cancer center: •47% prioritized quality of life •15% prioritized survival •38% prioritized both Importantly, prioritizing quality of life did not mean worse survival.
academic.oup.com
Abstract. Older adults with cancer often face decisions about prioritizing quality of life, survival, or both. In this prospective study of 181 patients ag
0
1
8
Excited to share our editorial on the role of immunotherapy combinations after progression on Chemo-IO in advanced NSCLC! https://t.co/tWn600QdT7
@CharuAggarwalMD @MMarmarelis @ASCO
#ASCODailyNews
dailynews.ascopubs.org
Adding immunomodulatory agents or targeted therapies to a PD-L1/PD-1–directed immunotherapy backbone has shown promise after progression on first-line chemotherapy and single-agent immunotherapy in...
0
7
15
🚀Check out this new case report in @JCardioEP 📷 "From Failure to Success: Lithotripsy Transforms Lead Extraction in a Same-Patient Case" by @G_Goldar & Edward M. Powers https://t.co/9ll8M5T3tR
onlinelibrary.wiley.com
Introduction Cardiac implantable electronic device infections often necessitate extraction, which can be complicated by calcified adhesions, leading to increased procedural risk and reduced efficac...
1
3
2
🚨 New in @OncJournal : Our study on treatment priorities in older adults with cancer. In a prospective cohort of 181 pts ≥65, we asked: Does valuing QOL over survival compromise outcomes? No. https://t.co/xHjXU6byM9 Led by @PennMedicine fellow @chefaleixomd @PC3Innovation
academic.oup.com
Abstract. Older adults with cancer often face decisions about prioritizing quality of life, survival, or both. In this prospective study of 181 patients ag
1
2
4
Older age and female sex predicted preference for quality of life in our 181-pt cohort; other factors didn’t—so we must ask, not assume.
Quality or Quantity of Life? Treatment Priorities in Older Adults with #Cancer in the Community. https://t.co/h32Jmwj25B
@OncJournal @ramsedhom @myCARG
#GeriOnc #Geriatrics #PallOnc
1
0
4
Quality or Quantity of Life? Treatment Priorities in Older Adults with #Cancer in the Community. https://t.co/h32Jmwj25B
@OncJournal @ramsedhom @myCARG
#GeriOnc #Geriatrics #PallOnc
3
10
22
Overall Survival with Inavolisib in PIK3CA-Mutated Advanced Breast Cancer (INAVO120) https://t.co/HPDpZkTJuM
0
20
75
#TumorBoardTuesday 🧑🎓Did you learn about HIF1 20+y ago❓ 🥸Well now we have agents to target🎯this key pathway👏 📢Join us Tuesday, 06-24-25 at 8PM ET as @Brian_rini & @paulosiqamaral🗣️the use of HIF⛔️in clear cell RCC #kidneycancer RT and bring others into the discussion‼️
1
12
32
@islamsadek18 @mpdrc @ASH_hematology @MikkaelSekeres @jmikhaelmd @AtriumHealth @AtriumHealthWFB @LevineCancer This is an unprecedented investment by ASH to support hematology research for an additional 600 recipients at all career stages and brings the total amount to be funded by ASH for research awards (new and existing grant programs) to $20 million over the next 12 months.
0
5
21
Our new diagnostic score to help distinguish Acquired AA from IBMFS. Honored to receive the Stanley Bradley Award for Clinical Science Research. Grateful for the incredible mentorship of Dr. Babushok!
2
1
31
Here is our poster with the implementation of the PGA in 3 community hospitals
#PC3IatASCO: @chefaleixomd, @ramsedhom, @efratdotan, & @ravi_b_parikh evaluating implementation of the Practical #Geriatric Assessment & resulting #chemotherapy dose modification among older adults with #cancer. #ASCO25 @ASCO
https://t.co/Fku5gE1lBS
https://t.co/BNaC4EvSem
1
3
28
#PC3IatASCO: @chefaleixomd, @ramsedhom, @efratdotan, & @ravi_b_parikh evaluating implementation of the Practical #Geriatric Assessment & resulting #chemotherapy dose modification among older adults with #cancer. #ASCO25 @ASCO
https://t.co/Fku5gE1lBS
https://t.co/BNaC4EvSem
1
3
7
Congratulations to @AgrimaMianMD for receiving the Research Training Award for Fellows - @jamecancerdoc
https://t.co/8EFahEF5G0
#OncoDaily #Oncology #Cancer #Health #Medicine #MedX
0
1
12
This 40 under 40 recognition from @avbcancercare is a great honor, and reflects #geriOnc #pallonc #psychoonc is cancer care I was drawn to oncology by the privilege of caring for the vulnerable & enjoy building systems that prioritize care of the whole person
13
5
52
The Spring 2025 #HealthEquity Scholars with Dr. Harlan Pinto of @StanfordDeptMed @StanfordCancer. Cc: @chefaleixomd, @egarcon, @mazomd
Congratulations to the Spring 2025 recipients of the Edith Peterson Mitchell, MD #HealthEquity Travel Scholarship! #EAOnc 🩺
0
2
2
Tumor-Infiltrating Clonal Hematopoiesis | New England Journal of Medicine
nejm.org
Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related condition associated with increased mortality among patients with cancer. CHIP mutations with high variant-allele frequencie...
0
1
12